1. Israel Stocks

  2. •

    Health technology

  3. •

    Biotechnology
IBI SILVER CASTLE LTD

IBI SILVER CASTLE LTD

TTASE:IBIS
2,489.00
ILA
+81.00
(+3.36%)
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
219.15
298.94
13.4
6.64
4.43
4.59
2.88
22.81
229.5
0.43
16.38
18.85
4.04
- -
Basic EPS, GAAP
-611.19
-401.79
-319.93
-266.6
-253.32
-158.28
-242.98
-83.23
-576.41
-21.41
-35.1
-32.86
-28.15
- -
Free Cash Flow per Basic Share
-537.81
-517.2
-282.58
-273.17
-219.29
-221.54
-160.38
-60.1
-408.6
-6.61
-22.9
-17.8
-6.81
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
323.82
234.44
400.29
131.81
-116.67
512.66
71.64
12.54
14.27
-14.53
-31.97
1.81
-19.64
-0.96
Tangible Book Value per Share
145.97
140.74
362.29
109.54
-116.67
512.66
71.64
12.54
14.27
-14.53
-31.97
1.81
-19.64
-0.96
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
1
Sales/Revenue/Turnover
1
2
- -
- -
- -
- -
- -
1
2
1
3
5
1
- -
Operating Margin (%)
-298.41
-130.92
-2,320.22
-3,994.79
-5,682.81
-3,979.05
-7,847.37
-355.2
-215.2
-4,597.2
-198.06
-162.04
-650.97
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-2
-2
-4
-4
-4
-4
-6
-3
-4
-32
-6
-9
-10
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-278.89
-134.4
-2,386.89
-4,015.62
-5,723.44
-3,450.48
-8,430.26
-364.91
-251.16
-4,963.04
-214.26
-174.29
-696.9
- -
Working Capital
3
3
7
3
- -
5
-3
-4
- -
-3
-6
- -
-7
-2
LT Debt
- -
- -
- -
- -
- -
- -
2
1
- -
1
1
- -
- -
- -
Total Equity
2
2
6
2
-2
7
2
- -
1
-2
-6
1
-7
-2
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-128.84
-113.06
-100.27
- -
- -
-137.76
-264.52
-815.2
- -
- -
- -
- -
- -

Capital Structure

ILS

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
- -
3
4
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
- -
2
Market Capitalization
- -
- -
- -

Working Capital

ILS

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
3
2
4
Cash, Cash Equivalents & STI
- -
- -
1
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
6
9
5
Payables & Accruals
- -
- -
- -
ST Debt
- -
3
4
Deferred Revenue
- -
- -
- -

Growth Rates

ILS

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-255.47%
-322.02%
-1,198.76%
Free Cash Flow
14.72%
33.58%
-48.9%
Net Income, GAAP
65.93%
130.32%
14.34%
Sales/Revenue/Turnover
137.23%
78.34%
-71.41%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

ILS

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
5
2025
- -
- -
1
2026
- -
- -
- -

Semi-annual Earnings Per Share

ILS

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-32.86
2025
- -
- -
-28.15
2026
- -
- -
- -

Semi-annual Dividends Per Share

ILS

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Eliezer Mizroach
Full Time Employees
10
Sector
Health technology
Industry
Biotechnology
Address
Tel Aviv Israel
IPO Date
May 18, 2006
Similar Companies
Moderna, Inc. (NASDAQ:MRNA)
Amgen Inc. (NASDAQ:AMGN)
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Novavax, Inc. (NASDAQ:NVAX)
10x Genomics, Inc. (NASDAQ:TXG)
Business
IBI Silver Castle Ltd. (TASE: IBIS) is an Israel-based financial services and investment management firm specializing in digital assets, blockchain-based financial products, and cryptocurrency investment solutions for institutional and accredited investors. Founded in 2018 and headquartered in Tel Aviv, Israel, the company operates as a pioneering digital asset investment house affiliated with IBI Investment House Ltd. The company provides a comprehensive suite of digital asset management and financial services organized across several core business segments: digital asset investment funds, including actively managed cryptocurrency portfolios, quantitative and algorithmic trading strategies, and exposure vehicles linked to major digital currencies such as Bitcoin and Ethereum; crypto-collateralized lending and credit facilities, providing liquidity and structured financing backed by digital asset collateral; institutional-grade digital asset custody management and safeguarding solutions, delivered in coordination with enterprise-grade security infrastructure providers; over-the-counter (OTC) digital asset brokerage and trade execution services; and blockchain financial consulting, encompassing corporate treasury management, digital asset risk advisory, and real-world asset tokenization solutions. The firm serves institutional investors, family offices, high-net-worth individuals, and corporate entities across Israel and international markets. In recent operational developments, the company completed a strategic integration and equity partnership with leading Israeli financial institution IBI Investment House Ltd., resulting in its corporate rebranding to IBI Silver Castle Ltd. and the expansion of its distribution network through institutional wealth channels. Additionally, the company has broadened its structured financing division with new crypto-backed credit products, forged enterprise security integrations with leading digital asset custodians including Fireblocks, and progressed its regulatory licensing under the Israeli Capital Market, Insurance and Savings Authority to support compliant digital asset trading, credit provision, and custody services.